AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial

Angela Puente Sanchez,Fanny Turon,Javier Martinez,Jose Ignacio Fortea,Manuel Hernandez-Guerra,Edilmar Alvarado-Tapias,Monica Pons,Marta Magaz,Elba Llop,Carmen Álvarez-Navascués, José Castellote Alonso,Marina Berenguer,Helena Masnou,Rafael Bañares,Marta Casado,Javier Ampuero,Georgina Casanovas,Carlos Redondo,Patricia Huelin,Luis Téllez

Journal of Hepatology（2023）

引用 0|浏览32
暂无评分
关键词
cirrhotic patients,moderate liver dysfunction,double-blind,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要